Acetic Acid Methyl Ester

Acetic Acid Methyl Ester

SCHEMBL28239396

COC(C)=O.N#CC1CCCC1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
HSD11B1 P28845 1/20 0.38
MAPK10 P53779 1/20 0.37
HPGD P15428 1/20 0.34
TSHR P16473 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CTSK P43235 2/20 0.33
DPP4 P27487 6/20 0.32
DPP8 Q6V1X1 4/20 0.32
DPP9 Q86TI2 4/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CTSB P07858 1/20 0.32
CTSS P25774 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL2861217 0.82 HPGD (0.36) ALDH1A1HSD11B1MAPK10HPGDCTSK
Ethyl Acetate SCHEMBL5389669 0.79 ALDH1A1 (0.50) ALDH1A1TSHRNPSR1CTSKCYP2D6
Acetic Acid SCHEMBL9843831 0.78 CA1 (0.35) HSD11B1MAPK10HPGDCTSKDPP4
Acetic Acid SCHEMBL9843899 0.78 CA1 (0.39) HSD11B1MAPK10HPGDCTSKDPP4
Bicarbonate SCHEMBL10618281 0.77 CES2 (0.38) ALDH1A1HSD11B1DPP4DPP8CYP3A4
SCHEMBL14051613 0.76 DPP4 (0.44) ALDH1A1DPP4DPP8DPP9CYP1A2
SCHEMBL56954 0.75
SCHEMBL10437830 0.75 CES2 (0.36) ALDH1A1HSD11B1DPP4DPP8CYP3A4
Formic Acid Methyl Ester SCHEMBL29242886 0.74 ADH1C (0.31)
Dimethylamine SCHEMBL9461913 0.74 EPHX1 (0.32) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108431007-A PYRAZOLOPYRIMIDINE DERIVATIVES AS BTK INHIBITORS FOR THE TREATMENT OF CANCER 洛克索肿瘤学股份有限公司 2018-08-21 CN disclosed